5,937 reports of this reaction
3.2% of all FLUTICASONE PROPIONATE reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for FLUTICASONE PROPIONATE, manufactured by Haleon US Holdings LLC. There are 5,937 FDA adverse event reports linking FLUTICASONE PROPIONATE to FATIGUE. This represents approximately 3.2% of all 187,924 adverse event reports for this drug.
Patients taking FLUTICASONE PROPIONATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among FLUTICASONE PROPIONATE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for FLUTICASONE PROPIONATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 5,937 FDA reports for FLUTICASONE PROPIONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.2% of all adverse event reports for FLUTICASONE PROPIONATE, making it one of the most commonly reported side effect.
If you experience fatigue while taking FLUTICASONE PROPIONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.